New study finds that these four major comorbidities increase the risk of death in patients with new corona
Cancer, chronic kidney disease, diabetes, and hypertension are the four main comorbidities that increase the risk of death in patients with new coronary disease. Researchers from Griffith University in Australia and other institutions recently published a paper in the US “Microbiology” online journal that they found that cancer, chronic kidney disease, diabetes and hypertension are the four main comorbidities that increase the risk of death in patients with new corona.
Comorbidities usually refer to a patient suffering from other diseases in addition to a major concern. According to the researchers, they analyzed data from multiple global databases such as the Dutch Scope database and the American Science Network, covering clinical data of more than 370,000 new study about crown patients in 14 countries and regions, and found that chronic kidney disease is statistically It is the most important comorbidity that increases the risk of death in patients with new corona.
The study also found that hypertension is the most common comorbidity in patients with new coronary disease, followed by obesity and diabetes. However, unlike hypertension and diabetes, obesity does not increase the risk of death for patients with new corona.
Adam Taylor, one of the authors of the paper and a Griffith University researcher, said that comorbidities are often considered to be a risk factor for worsening the condition of patients with new corona, but the extent to which specific comorbidities affect the condition of new corona is unclear. “This global study covers all comorbidities related to the deterioration of the new coronary disease and death. It allows us to identify comorbidities that are more risky for patients, as well as people who are at high risk for the new crown.”
The researchers said that further research is needed to further study why some comorbidities are more common in patients with new corona. For example, certain diabetes treatment drugs may increase the expression of viral receptors on human cells, thereby helping the new crown virus invade cells.